Felicia Gelsey, MS

Advisor
Eli Lilly and Company

Poster(s):

• (P109) Experience of People with T2D and Healthcare Providers Using Once-weekly Basal Insulin Efsitora Alfa in the QWINT Phase 3 Trials
  Saturday, August 9, 2025

  12:00 PM - 1:00 PM MST